Gollob Jared bought KYMR
December 8, 2025 · Form 4 insider transaction
Gollob Jared bought 49,307 shares of Kymera Therapeutics, Inc. at $5.33 per share, a transaction worth $262.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
49,307
Price
$5.33
Total value
$262.8K
InsiderGollob Jared
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 8, 2025
Shares owned after159,299
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 2, 2025 adopted by the reporting person.